Skip to main content
. 2019 Nov;8(7):2535–2542. doi: 10.21037/tcr.2019.10.16

Figure 3.

Figure 3

Subgroup analyses HR for JMJD5 in predicting PFS and OS. No significant difference in HR were found in subgroup analyses (all P values are >0.05). JMJD5, Jumonji domain containing 5; OS, overall survival; PFS, progression-free survival.